Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Defensin Market
Activin-A Market by Product Type, Formulation, Route Of Administration, Distribution Channel, End User, Application - Global Forecast 2026-2032
The Activin-A Market is projected to grow by USD 521.32 million at a CAGR of 6.55% by 2032. KEY MARKET STATISTICS Base Year [2025] USD 334.32 million Estimated Year [2026] USD 356.70 million Forecast Year [2032] USD 521.32 million CAGR (%) 6.55% Activin-A, encoded by INHBA and functioning as a dimeric member of the transforming growth factor-beta superfamily, is a high-value target across life sciences, biopharmaceutical research, diagnostics, and translational medicine.
Bioactive Protein and Peptides Market, By Source, By Application, By Geography
Bioactive Protein and Peptides Market is estimated to be valued at USD 13.5 Bn in 2026 and is expected to reach USD 18.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.
Activin-A Market by Application, Formulation, Route Of Administration, Product Type, Distribution Channel, End User - Global Forecast 2026-2032
The Activin-A Market was valued at USD 334.32 million in 2025 and is projected to grow to USD 356.70 million in 2026, with a CAGR of 6.55%, reaching USD 521.32 million by 2032.
Bioactive Peptide Market, By Source, By Therapeutic Area, By Distribution Channel, By Geography
Bioactive Peptide Market is estimated to be valued at USD 7,089.6 Mn in 2026 and is expected to reach USD 13,328.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.
Next Generation Drug Conjugates Market Analysis and Forecast to 2035: Type, Product, Technology, Application, End User, Service, Component, Stage, Deployment, Process
Next Generation Drug Conjugates Market is anticipated to expand from $4.9 billion in 2024 to $22.8 billion by 2034, growing at a CAGR of approximately 16.6%. The Next Generation Drug Conjugates Market encompasses innovative therapeutics combining active drugs with targeting molecules, enhancing precision in disease treatment. These conjugates improve efficacy and reduce side effects, particularly in oncology. Advances in bioconjugation techniques and novel payloads are propelling market growth.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Defensin
Contact Defensin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack